Ela Markovsky1, Sadna Budhu2, Robert M Samstein1, Hongyan Li1, James Russell3, Zhigang Zhang4, Esther Drill4, Chloe Bodden1, Qing Chen3, Simon N Powell1, Taha Merghoub2, Jedd D Wolchok2, John Humm3, Joseph O Deasy3, Adriana Haimovitz-Friedman5. 1. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 2. Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York. 3. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. 4. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. 5. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: a-haimovitz-friedman@ski.mskcc.org.
Abstract
PURPOSE: This study examined tumor growth delay resulting from partial irradiation in preclinical mouse models. METHODS AND MATERIALS: We investigated 67NR murine orthotopic breast tumors in both immunocompetent and nude mice. Treatment was delivered to 50% or 100% of the tumor using a 2 × 2 cm collimator on a microirradiator. Radiation response was modulated by treatment with anti-CD8 and anti-intercellular adhesion molecule (anti-ICAM) antibodies. Similar experiments were performed using the less immunogenic Lewis lung carcinoma mouse model. Tumor growth delay and γ-H2AX phosphorylation were measured, and immune response was assessed by immunofluorescence and flow cytometry at 1 and 7 days after radiation therapy. Tumor expression of cellular adhesion molecules was also measured at different times after radiation therapy. RESULTS: Partial irradiation led to tumor responses similar to those of fully exposed tumors in immunocompetent mice, but not in nude mice. After a single dose of 10 Gy, infiltration of CD8+ T cells was observed along with increased expression of ICAM. The response to 10 Gy in hemi-irradiated tumors was abrogated by treatment with either anti-CD8 or anti-ICAM antibodies. Similar responses were obtained in the less immunogenic Lewis lung carcinoma mouse model delivering 15 Gy to half the tumor volume. Treatment with FTY720, a compound that inhibits T-cell egress from lymph nodes, did not affect tumor response at the time of CD8+ T cells infiltration in the nonirradiated area of the tumor. This result indicated that the most likely source of these cells is the irradiated portion of the hemi-irradiated tumors. In addition, a significant abscopal effect was observed after partial irradiation with a single dose of 10 Gy in the 67NR model. CONCLUSIONS: In these models, radiation controls tumor growth both directly through cell killing and indirectly through immune activation. This outcome raises the possibility that this effect could be induced in the clinic.
PURPOSE: This study examined tumor growth delay resulting from partial irradiation in preclinical mouse models. METHODS AND MATERIALS: We investigated 67NR murine orthotopic breast tumors in both immunocompetent and nude mice. Treatment was delivered to 50% or 100% of the tumor using a 2 × 2 cm collimator on a microirradiator. Radiation response was modulated by treatment with anti-CD8 and anti-intercellular adhesion molecule (anti-ICAM) antibodies. Similar experiments were performed using the less immunogenic Lewis lung carcinomamouse model. Tumor growth delay and γ-H2AX phosphorylation were measured, and immune response was assessed by immunofluorescence and flow cytometry at 1 and 7 days after radiation therapy. Tumor expression of cellular adhesion molecules was also measured at different times after radiation therapy. RESULTS: Partial irradiation led to tumor responses similar to those of fully exposed tumors in immunocompetent mice, but not in nude mice. After a single dose of 10 Gy, infiltration of CD8+ T cells was observed along with increased expression of ICAM. The response to 10 Gy in hemi-irradiated tumors was abrogated by treatment with either anti-CD8 or anti-ICAM antibodies. Similar responses were obtained in the less immunogenic Lewis lung carcinomamouse model delivering 15 Gy to half the tumor volume. Treatment with FTY720, a compound that inhibits T-cell egress from lymph nodes, did not affect tumor response at the time of CD8+ T cells infiltration in the nonirradiated area of the tumor. This result indicated that the most likely source of these cells is the irradiated portion of the hemi-irradiated tumors. In addition, a significant abscopal effect was observed after partial irradiation with a single dose of 10 Gy in the 67NR model. CONCLUSIONS: In these models, radiation controls tumor growth both directly through cell killing and indirectly through immune activation. This outcome raises the possibility that this effect could be induced in the clinic.
Authors: Lin Yang; Richard M Froio; Tracey E Sciuto; Ann M Dvorak; Ronen Alon; Francis W Luscinskas Journal: Blood Date: 2005-04-05 Impact factor: 22.113
Authors: Joseph M Kaminski; Eric Shinohara; James Bradley Summers; Kenneth J Niermann; Allan Morimoto; Jeffrey Brousal Journal: Cancer Treat Rev Date: 2005-05 Impact factor: 12.111
Authors: D H Gorski; M A Beckett; N T Jaskowiak; D P Calvin; H J Mauceri; R M Salloum; S Seetharam; A Koons; D M Hari; D W Kufe; R R Weichselbaum Journal: Cancer Res Date: 1999-07-15 Impact factor: 12.701
Authors: Mala Chakraborty; Scott I Abrams; C Norman Coleman; Kevin Camphausen; Jeffrey Schlom; James W Hodge Journal: Cancer Res Date: 2004-06-15 Impact factor: 12.701
Authors: Sandra Demaria; Bruce Ng; Mary Louise Devitt; James S Babb; Noriko Kawashima; Leonard Liebes; Silvia C Formenti Journal: Int J Radiat Oncol Biol Phys Date: 2004-03-01 Impact factor: 7.038
Authors: Andrew J Johnsrud; Samir V Jenkins; A Jamshidi-Parsian; Charles M Quick; Edvaldo P Galhardo; Ruud P M Dings; Kieng B Vang; Ganesh Narayanasamy; Issam Makhoul; Robert J Griffin Journal: Radiat Res Date: 2020-12-01 Impact factor: 2.841
Authors: Alice Y Ho; Jean L Wright; Rachel C Blitzblau; Robert W Mutter; Dan G Duda; Larry Norton; Aditya Bardia; Laura Spring; Steven J Isakoff; Jonathan H Chen; Clemens Grassberger; Jennifer R Bellon; Sushil Beriwal; Atif J Khan; Corey Speers; Samantha A Dunn; Alastair Thompson; Cesar A Santa-Maria; Ian E Krop; Elizabeth Mittendorf; Tari A King; Gaorav P Gupta Journal: Int J Radiat Oncol Biol Phys Date: 2020-05-14 Impact factor: 7.038
Authors: Jonathan Khalifa; Julien Mazieres; Carlos Gomez-Roca; Maha Ayyoub; Elizabeth Cohen-Jonathan Moyal Journal: Front Oncol Date: 2021-04-21 Impact factor: 6.244
Authors: Timothy R Johnson; Alex M Bassil; Nerissa T Williams; Simon Brundage; Collin L Kent; Greg Palmer; Yvonne M Mowery; Mark Oldham Journal: Phys Med Biol Date: 2022-02-18 Impact factor: 4.174
Authors: M Massaccesi; L Boldrini; A Piras; G Stimato; F Quaranta; L Azario; G C Mattiucci; V Valentini Journal: Tech Innov Patient Support Radiat Oncol Date: 2020-03-02
Authors: Jason J Luke; Benjamin E Onderdonk; Sean P Pitroda; Steven J Chmura; Sandeep R Bhave; Theodore Karrison; Jeffrey M Lemons; Paul Chang; Yuanyuan Zha; Tim Carll; Thomas Krausz; Lei Huang; Carlos Martinez; Linda A Janisch; Robyn D Hseu; John W Moroney; Jyoti D Patel; Nikolai N Khodarev; Joseph K Salama; Patrick A Ott; Gini F Fleming; Thomas F Gajewski; Ralph R Weichselbaum Journal: Clin Cancer Res Date: 2020-10-07 Impact factor: 12.531